NCT04998175 Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)
| NCT ID | NCT04998175 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Idiopathic Normal Pressure Hydrocephalus |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2020-09-15 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2020-09-15 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The research is designed to study the prognostic factors of ventriculoperitoneal (VP) shunt for iNPH by multi-omics research
Eligibility Criteria
Inclusion Criteria: * Age ≥ 60 years; * Diagnosis of iNPH based on clinical assessment * Participant is able to give written informed consent Exclusion Criteria: * Combining AD and Parkinson's disease and other nervous system diseases * Participant is not medically available for shunt surgery * Secondary NPH
Contact & Investigator
Zhoule Zhu
PRINCIPAL INVESTIGATOR
Second Affiliated Hospital, School of Medicine, Zhejiang University
Frequently Asked Questions
Who can join the NCT04998175 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 90 Years, studying Idiopathic Normal Pressure Hydrocephalus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04998175 currently recruiting?
Yes, NCT04998175 is actively recruiting participants. Contact the research team at dr.zhujunming@zju.edu.cn for enrollment information.
Where is the NCT04998175 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT04998175 clinical trial?
NCT04998175 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The principal investigator is Zhoule Zhu at Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 40 participants.